✦ LIBER ✦

Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506)

✍ Scribed by M.R. Kramer; G. Merin; E. Rudis; I. Bar; T. Nesher; M. Bublil; E. Milgalter

Book ID: 117235078
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 218 KB
Volume: 29
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(97)00546-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Itraconazole Prophylaxis in Lung Transpl

Itraconazole Prophylaxis in Lung Transplant Recipients Receiving Tacrolimus (FK 506): Efficacy and Drug Interaction

✍ David Shitrit; Jacob E. Ollech; Ayelet Ollech; Ilana Bakal; Milton Saute; Gideon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 101 KB

Voriconazole and itraconazole in lung tr

Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction

✍ Mordechai R. Kramer; Anat Amital; Leonardo Fuks; David Shitrit 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Occurrence of gammopathies and lymphopro

Occurrence of gammopathies and lymphoproliferative disorders in liver transplant recipients randomized to tacrolimus (FK506)- or cyclosporine-based immunosuppression

✍ Pham, Hung ;Lemoine, Antoinette ;Salvucci, Marina ;Azoulay, Daniel ;Frenoy, Nico 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 110 KB

Lymphoproliferative disorders (LPDs) are a serious side effect of immunosuppression after liver transplantation, and the introduction on the market of a new immunosuppressive drug has been associated with an increased risk of these disorders. To compare the effect of cyclosporine A (CSA) and FK506 i

Predictors and outcome of early- versus

Predictors and outcome of early- versus late-onset major bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression

✍ N. Singh; T. Gayowski; M. M. Wagener; I. R. Marino 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 613 KB